STOCK TITAN

[8-K] Bain Capital Specialty Finance, Inc. Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

Resideo Technologies, Inc. (REZI) filed a Form 144 disclosing a planned disposition of 5,579 common shares via Morgan Stanley Smith Barney on 07 July 2025. The stock originates from restricted stock units granted on 16 November 2022 and carries an estimated market value of $134,342. With 148,503,534 shares currently outstanding, the sale equals roughly 0.004 % of total shares—an amount generally viewed as immaterial to the company’s float. The filer reported no other sales in the past three months, and the notice contains no commentary on company operations or outlook.

Resideo Technologies, Inc. (REZI) ha presentato un modulo 144 comunicando una prevista vendita di 5.579 azioni ordinarie tramite Morgan Stanley Smith Barney il 07 luglio 2025. Le azioni derivano da unità azionarie vincolate assegnate il 16 novembre 2022 e hanno un valore di mercato stimato di 134.342 $. Con 148.503.534 azioni attualmente in circolazione, la vendita rappresenta circa lo 0,004% del totale delle azioni, una quantità generalmente considerata irrilevante per il flottante della società. Il dichiarante ha segnalato nessun'altra vendita negli ultimi tre mesi e l’avviso non contiene commenti sulle operazioni o sulle prospettive dell’azienda.

Resideo Technologies, Inc. (REZI) presentó un Formulario 144 notificando una disposición planificada de 5,579 acciones ordinarias a través de Morgan Stanley Smith Barney el 07 de julio de 2025. Las acciones provienen de unidades de acciones restringidas otorgadas el 16 de noviembre de 2022 y tienen un valor de mercado estimado de $134,342. Con 148,503,534 acciones actualmente en circulación, la venta representa aproximadamente el 0.004% del total de acciones, una cantidad generalmente considerada insignificante para el float de la empresa. El declarante reportó ninguna otra venta en los últimos tres meses y el aviso no incluye comentarios sobre las operaciones o perspectivas de la empresa.

Resideo Technologies, Inc. (REZI)는 2025년 7월 7일 Morgan Stanley Smith Barney를 통해 5,579주 보통주 처분 계획을 공시하는 Form 144를 제출했습니다. 해당 주식은 2022년 11월 16일 부여된 제한 주식 단위에서 기인하며, 추정 시장 가치는 $134,342입니다. 현재 148,503,534주가 발행 중인 가운데, 이번 매도는 전체 주식의 약 0.004%에 해당하며, 이는 일반적으로 회사 유통 주식 수에 대해 무시할 수 있는 수준으로 간주됩니다. 신고자는 최근 3개월간 다른 매도 내역이 없음을 보고했으며, 공시에는 회사 운영이나 전망에 대한 언급이 포함되어 있지 않습니다.

Resideo Technologies, Inc. (REZI) a déposé un formulaire 144 divulguant une cession prévue de 5 579 actions ordinaires via Morgan Stanley Smith Barney le 7 juillet 2025. Les actions proviennent de unités d’actions restreintes accordées le 16 novembre 2022 et ont une valeur marchande estimée à 134 342 $. Avec 148 503 534 actions actuellement en circulation, la vente représente environ 0,004 % du total des actions – un montant généralement considéré comme négligeable pour le flottant de la société. Le déclarant a indiqué aucune autre vente au cours des trois derniers mois et l’avis ne contient aucun commentaire sur les opérations ou les perspectives de l’entreprise.

Resideo Technologies, Inc. (REZI) hat ein Formular 144 eingereicht, in dem ein geplanter Verkauf von 5.579 Stammaktien über Morgan Stanley Smith Barney am 07. Juli 2025 offengelegt wird. Die Aktien stammen von eingeschränkten Aktieneinheiten, die am 16. November 2022 gewährt wurden, und haben einen geschätzten Marktwert von 134.342 $. Bei derzeit 148.503.534 ausstehenden Aktien entspricht der Verkauf etwa 0,004% der Gesamtaktien – ein Betrag, der in der Regel als unerheblich für den Streubesitz des Unternehmens angesehen wird. Der Melder gab an, in den letzten drei Monaten keine weiteren Verkäufe getätigt zu haben, und die Mitteilung enthält keine Kommentare zu den Geschäftstätigkeiten oder der Zukunftsaussicht des Unternehmens.

Positive
  • None.
Negative
  • None.

Insights

TL;DR Routine Form 144 for 5,579 REZI shares (~$134k); negligible 0.004% float impact, signalling standard insider liquidity.

The filing outlines a modest prospective insider sale valued at $134k. Given the company’s 148.5 million shares outstanding, the transaction is far below any threshold that would influence liquidity, ownership structure, or market sentiment. No accompanying material disclosures or pattern of selling were noted. I view the event as operationally neutral and unlikely to affect valuation or trading dynamics.

TL;DR Insider intends minor sale under Rule 144; governance significance minimal.

Rule 144 filings ensure transparency for insider dispositions. The absence of additional sales over the prior quarter and the tiny proportion of stock involved (<0.01%) suggest the move is personal liquidity rather than a governance red flag. There is no indication of undisclosed adverse information. Overall, the filing maintains compliance without raising governance concerns.

Resideo Technologies, Inc. (REZI) ha presentato un modulo 144 comunicando una prevista vendita di 5.579 azioni ordinarie tramite Morgan Stanley Smith Barney il 07 luglio 2025. Le azioni derivano da unità azionarie vincolate assegnate il 16 novembre 2022 e hanno un valore di mercato stimato di 134.342 $. Con 148.503.534 azioni attualmente in circolazione, la vendita rappresenta circa lo 0,004% del totale delle azioni, una quantità generalmente considerata irrilevante per il flottante della società. Il dichiarante ha segnalato nessun'altra vendita negli ultimi tre mesi e l’avviso non contiene commenti sulle operazioni o sulle prospettive dell’azienda.

Resideo Technologies, Inc. (REZI) presentó un Formulario 144 notificando una disposición planificada de 5,579 acciones ordinarias a través de Morgan Stanley Smith Barney el 07 de julio de 2025. Las acciones provienen de unidades de acciones restringidas otorgadas el 16 de noviembre de 2022 y tienen un valor de mercado estimado de $134,342. Con 148,503,534 acciones actualmente en circulación, la venta representa aproximadamente el 0.004% del total de acciones, una cantidad generalmente considerada insignificante para el float de la empresa. El declarante reportó ninguna otra venta en los últimos tres meses y el aviso no incluye comentarios sobre las operaciones o perspectivas de la empresa.

Resideo Technologies, Inc. (REZI)는 2025년 7월 7일 Morgan Stanley Smith Barney를 통해 5,579주 보통주 처분 계획을 공시하는 Form 144를 제출했습니다. 해당 주식은 2022년 11월 16일 부여된 제한 주식 단위에서 기인하며, 추정 시장 가치는 $134,342입니다. 현재 148,503,534주가 발행 중인 가운데, 이번 매도는 전체 주식의 약 0.004%에 해당하며, 이는 일반적으로 회사 유통 주식 수에 대해 무시할 수 있는 수준으로 간주됩니다. 신고자는 최근 3개월간 다른 매도 내역이 없음을 보고했으며, 공시에는 회사 운영이나 전망에 대한 언급이 포함되어 있지 않습니다.

Resideo Technologies, Inc. (REZI) a déposé un formulaire 144 divulguant une cession prévue de 5 579 actions ordinaires via Morgan Stanley Smith Barney le 7 juillet 2025. Les actions proviennent de unités d’actions restreintes accordées le 16 novembre 2022 et ont une valeur marchande estimée à 134 342 $. Avec 148 503 534 actions actuellement en circulation, la vente représente environ 0,004 % du total des actions – un montant généralement considéré comme négligeable pour le flottant de la société. Le déclarant a indiqué aucune autre vente au cours des trois derniers mois et l’avis ne contient aucun commentaire sur les opérations ou les perspectives de l’entreprise.

Resideo Technologies, Inc. (REZI) hat ein Formular 144 eingereicht, in dem ein geplanter Verkauf von 5.579 Stammaktien über Morgan Stanley Smith Barney am 07. Juli 2025 offengelegt wird. Die Aktien stammen von eingeschränkten Aktieneinheiten, die am 16. November 2022 gewährt wurden, und haben einen geschätzten Marktwert von 134.342 $. Bei derzeit 148.503.534 ausstehenden Aktien entspricht der Verkauf etwa 0,004% der Gesamtaktien – ein Betrag, der in der Regel als unerheblich für den Streubesitz des Unternehmens angesehen wird. Der Melder gab an, in den letzten drei Monaten keine weiteren Verkäufe getätigt zu haben, und die Mitteilung enthält keine Kommentare zu den Geschäftstätigkeiten oder der Zukunftsaussicht des Unternehmens.

false 0001655050 0001655050 2025-06-30 2025-06-30
 
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): June 30, 2025

 

 

BAIN CAPITAL SPECIALTY FINANCE, INC.

(Exact name of Registrant as Specified in Its Charter)

 

 

 

Delaware   814-01175   81-2878769

(State or Other Jurisdiction

of Incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

200 Clarendon Street

37th Floor

 
Boston, Massachusetts   02116
(Address of Principal Executive Offices)   (Zip Code)

Registrant’s Telephone Number, Including Area Code: (617) 516-2000

N/A

(Former Name or Former Address, if Changed Since Last Report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading
Symbol(s)

 

Name of each exchange

on which registered

Common Stock, par value $0.001 per share   BCSF   New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 
 


Item 5.02.

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On June 30, 2025, Jessica Yeager resigned from her position as Vice President of Bain Capital Specialty Finance, Inc. (the “Company”) in order to pursue other professional opportunities. Ms. Yeager’s resignation is not a result of any disagreement with the Company.

The Board appointed Adriana Rojas Garzón as Vice President of the Company effective as of the close of business on June 30, 2025. Ms. Rojas Garzón is a Vice President and Associate General Counsel, Capital Markets. Ms. Rojas Garzón joined Bain Capital in 2010.

Ms. Rojas Garzón has no family relationships with any current director, executive officer, or person nominated to become a director or executive officer of the Company, and there are no transactions or proposed transactions to which the Company is a party, or intended to be a party, in which Ms. Rojas Garzón has, or will have, a material interest subject to Item 404(a) of Regulation S-K.

 

Item 9.01.

Financial Statements and Exhibits.

(d) Exhibits

 

Exhibit
No.

  

Description

104    Cover Page Interactive Data File (embedded within the Inline XBRL document).


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    BAIN CAPITAL SPECIALTY FINANCE, INC.
Date: July 7, 2025     By:  

/s/ Adriana Rojas Garzón

    Name:   Adriana Rojas Garzón
    Title:   Vice President

FAQ

How many Resideo (REZI) shares are being sold under this Form 144?

5,579 common shares are proposed for sale.

What is the estimated market value of the REZI shares to be sold?

The filing lists an aggregate value of $134,342.32.

What percentage of Resideo’s outstanding shares does the sale represent?

Approximately 0.004 % of the 148,503,534 shares outstanding.

When were the shares originally acquired by the insider?

They were acquired on 16 November 2022 as restricted stock units.

On what date may the proposed sale take place?

The approximate sale date provided is 07 July 2025.

Which broker is handling the transaction for the insider?

The broker of record is Morgan Stanley Smith Barney LLC, Executive Financial Services.
Bain Capital Specialty Finance Inc

NYSE:BCSF

BCSF Rankings

BCSF Latest News

BCSF Latest SEC Filings

BCSF Stock Data

999.62M
62.48M
0.59%
55.44%
0.56%
Asset Management
Financial Services
Link
United States
BOSTON